Ryan Lake - Feb 3, 2022 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Financial Officer
Signature
Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Feb 3, 2022
Transactions value $
-$1,572
Form type
4
Date filed
2/4/2022, 03:41 PM
Previous filing
Feb 2, 2022
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability -$1.57K -1.02K -0.19% $1.54 545K Feb 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.